About | Free Trial

Last Update

2016-05-18T00:00:00.000Z

This profile was last updated on . .

Is this you? Claim your profile.

Wrong Martin Landray?

Dr. Martin Landray J.

Professor of Medicine and Epidemiology

Oxford University

Direct Phone: +44 **********       

Oxford University

Background Information

Affiliations

Fellow
British Pharmacological Society

Fellow
Higher Education Academy

Fellow
Royal College of Physicians

Fellow
American Society of Nephrology

Team Member
Clinical Trials Transformation Initiative (CTTI)

Board Member
NIHR Commissioning

Advisor To the Initiative
Food and Drug Administration

Education

MD

University of Oxford

Web References (79 Total References)


Our team — Nuffield Department of Population Health

www.ndph.ox.ac.uk [cached]

Martin Landray

...
Martin Landray
...
Martin Landray
...
Martin Landray


NIHR Evaluation, Trials and Studies | Our people

www.nets.nihr.ac.uk [cached]

Dr Martin Landray Professor of Medicine and Epidemiology, University of Oxford


with Professor Martin ...

www.ndph.ox.ac.uk [cached]

with Professor Martin Landray

A wealth of new and advancing technologies are changing the way we approach research in healthcare. The use of big data sets, precision medicine and machine learning mean that research studies can be bigger, cheaper and wider reaching than ever before. In this lecture, Professor Martin Landray, Deputy Director of the Big Data Institute, and Professor of Medicine and Epidemiology at the University of Oxford, considered how recent advancements in healthcare technologies have radically changed how we go about medical research, and look at how future innovations could further shape the field.
Join in on Twitter #tomorrowtech
Martin Landray is Professor of Medicine and Epidemiology within the Nuffield Department of Population Health and Deputy Director of the Big Data Institute within the Li Ka Shing Centre for Health Information and Discovery.


Professor Martin Landray ...

www.ukbiobank.ac.uk [cached]

Professor Martin Landray (University of Oxford)


Opposing were Martin ...

www.bioworld.com [cached]

Opposing were Martin Landray, professor of medicine and epidemiology, at the University of Oxford, in the U.K., and Bettina Ryll, the Uppsala, Sweden-based founder of Melanoma Patient Network Europe.

...
Landray countered that the current problems arise from an absence of or inadequate engineering. He cast poor interpretation and misapplication of regulations and an overly cautious approach to technology as the "enemies of innovation. He argued for a quality-by-design approach to clinical development, which builds on a culture of critical thinking, focusing efforts on essential activities and focus on errors that matter, while building broad stakeholder engagement. All of these are principles of engineering design, he said. "Our failure has been to apply those principles closely," he said. "It's not overengineering is the problem - it's forgetting to engineer is the problem."
He defended regulators, who have made valuable inputs into new development approaches, such as quality by design, risk-based management and risk-proportionate studies "All these things come out of working with regulators," he said.
...
"We agree that trials are too expensive, too slow, highly wasteful and do not address the questions we want," Landray said. "That's not overengineering - that's insanity."
By the close of the debate, Landray and Ryll had managed to shift the audience significantly.

Similar Profiles

Other People with this Name

Other people with the name Landray

Paul Landray
RouteOne LLC

Paul Landray
Ford University

Ted Landray
Exeter University

Robert Landray
Gazprom Marketing & Trading Ltd

Liz Landray
Boroondara

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory